Bryan K. Gathagan bought $6,320 of ICCC
director at IMMUCELL CORP /DE/. 1,000 shares at an average of $6.32, traded Jun 12, 2025, filed Jun 12, 2025.
Score components
- +15RoleDirector
- 0Trade size$6k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- 0Price contextNo price history yet
- 0ClusterNo other insider buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +1.1%, 3m -4.4%, 6m -5.3%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001213900-25-053904, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jun 12, 2025 | POpen-market purchase Common stock $0.10 per value per share | +1,000 | $6.32 | $6,320 | 1,000 | Jun 12, 2025 |
Related signals
Other insiders at IMMUCELL CORP /DE/ and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 43Moderate | ICCCbuy IMMUCELL CORP /DE/ | Boekhorst Paul Francis Olivier te President and CEO | $76k 8,000 shares | +82% | |
| 53Moderate | IMMUCELL CORP /DE/ | Boekhorst Paul Francis Olivier te President and CEO | $32k 6,030 shares | +163% | |
| 48Moderate | IMMUCELL CORP /DE/ | Boekhorst Paul Francis Olivier te President and CEO | $49k 9,785 shares | - | |
| 26Weak | IMMUCELL CORP /DE/ | David Scott Tomsche director | $16k 3,266 shares | +6% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.